Invesco NASDAQ Biotech UCITS ETF | SBIORegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 16,4 | 7,0 | -6,1 | 2,8 | -1,9 | |
+/-Kat | -2,4 | 10,1 | 6,7 | 1,5 | 0,4 | |
+/-Indeks | -9,0 | 0,1 | -3,0 | -7,4 | -10,0 | |
Kategori: Sektor - Bioteknologi, Aktier | ||||||
Kategoribenchmark: Morningstar Gbl Biotechnolo... |
Oversigt | ||
Closing Price 13-05-2024 | USD 45,28 | |
Kursændring 1 dag | 0,45% | |
Morningstar Kategori™ | Sektor - Bioteknologi, Aktier | |
Omsætning | 3520 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BQ70R696 | |
Markedsværdi i alt (mio.) 10-05-2024 | USD 333,24 | |
Seneste TNA(mio.) 10-05-2024 | USD 333,24 | |
Løbende omkostning 26-03-2024 | 0,40% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Invesco NASDAQ Biotech UCITS ETF | SBIO |
The investment objective of the Fund is to achieve the total return performance of the NASDAQ Biotechnology Index (the "Reference Index") less fees, expenses and transaction costs. The Reference Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market®. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
- - | ||
Startdato 06-11-2014 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
NASDAQ Biotechnology TR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling Invesco NASDAQ Biotech UCITS ETF | SBIO | 31-03-2024 |
|
|
Top 5 placeringer | Sektor | % |
TRS NASDAQ Biotechnology TR USD | 100,00 | |
Øget Mindsket Ny siden sidste portefølje | ||
Invesco NASDAQ Biotech UCITS ETF | SBIO |